$56.98
Value $1.9B
AEHR and AMD stock compared: price, dividend, valuation and results, from SEC filings.
$56.98
Value $1.9B
$534.06
Value $871B
Aehr Test Systems (AEHR) has a market value of $1.9B and Advanced Micro Devices (AMD) $871B. Over the last year, with dividends, AEHR moved +145.4% and AMD +106.3%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
AEHR$1.9B
AMD$871B
AMD is 468 times AEHR
Revenue, 12 months
AEHR$50M
AMD$45.4B
AMD is 909 times AEHR
Net income, 12 months
AEHR-$7.1M
AMD$7.6B
Operating margin
AEHR-28.3%
AMD17.7%
46.0 points apart
ROIC
AEHR-5.1%
AMD9.3%
14.4 points apart
P/E
AEHR–
AMD114.3
Dividend yield
AEHR0.0%
AMD0.0%
About the same
5-year return
AEHR+129.9%
AMD+261.1%
131.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
AEHR+129.9%
AMD+261.1%
| Period | AEHRWith dividends | AMDWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +145.4%Price +145.4% | +106.3%Price +106.3% |
| 3 years since November 13, 2023 | +143.5%+34.5% a yearPrice +143.5% | +357.3%+66.0% a yearPrice +357.3% |
| 5 years since November 12, 2021 | +129.9%+18.1% a yearPrice +129.9% | +261.1%+29.3% a yearPrice +261.1% |
| 10 years since November 15, 2016 | +1,812.1%+34.3% a yearPrice +1,812.1% | +7,562.3%+54.3% a yearPrice +7,562.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
AEHRAehr Test SystemsAMDAdvanced Micro Devices
| Price | $56.98 | $534.06 |
|---|---|---|
| Market value | $1.9B | $871B |
| Enterprise value (EV) | $1.8B | $862B |
| P/E | – | 114.3 |
| P/E, 5-year median | 24.7 | 77.1 |
| P/B | 8.4 | 12.7 |
| EV/EBIT | – | 107.1 |
| Free cash flow yield | – | 0.8% |
| Revenue, 12 months | $50M | $45.4B |
|---|---|---|
| Net income, 12 months | -$7.1M | $7.6B |
| Free cash flow, 12 months | -$5.4M | $7.1B |
| Earnings per share, 12 months | -$0.23 | $4.60 |
| Revenue growth, year on year | -15.2% | 34.3% |
| Revenue growth a year, past | +24.7%over 5 years | +28.8%over 5 years |
| EPS growth a year, past | – | +5.2%over 5 years |
| Gross margin | 35.3% | 53.7% |
|---|---|---|
| Operating margin | -28.3% | 17.7% |
| Net margin | -14.2% | 16.8% |
| ROIC | -5.1% | 9.3% |
| ROE | -3.3% | 11.8% |
| Cash | $105M | $15.8B |
|---|---|---|
| Total debt | $9.8M | $9.2B |
| Net debt / EBITDA | – | -1.0 |
| Interest cover | – | 46.8× |
| Dividend yield | – | – |
|---|---|---|
| Dividend per share, 12 months | – | – |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 0.2% |
| Shareholder yield | – | 0.2% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Advanced Micro Devices ($871B) is about 468.5 times Aehr Test Systems ($1.9B), at today's prices.
Since November 15, 2016, AEHR's price moved +1,812.1% and AMD's +7,562.3%. With dividends: AEHR +1,812.1% (+34.3% a year), AMD +7,562.3% (+54.3% a year). Past returns do not predict future ones.
Neither paid a dividend over the last twelve months: Aehr Test Systems and Advanced Micro Devices return money to shareholders, if they do, in other ways, such as buybacks.
Over the last twelve months, the net margin was -14.2% for Aehr Test Systems and 16.8% for Advanced Micro Devices, and the operating margin -28.3% and 17.7%. Revenue was $50M and $45.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.